KPNA2 and cancer: When treated with cisplatin and 5-fluorouracil (5-FU), 344SQ cells cocultured with Kpna2-overexpressing LFs were more resistant to these anticancer drugs than those cocultured with control LFs (Figure S2), suggesting that KPNA2-high CAFs endow cancer cells with drug resistance.